Small Cap Healthcare
Stocks Ranked by
Market Capitalization
Small Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 329 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $285B.
The largest by market cap are NovoCure (NVCR) at $1.99B, Sarepta Therapeutics (SRPT) at $1.98B and Taysha Gene Therapies (TSHA) at $1.98B.
Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 147 funds opened new positions.
- Combined market cap: $285B across 329 stocks.
- Small Cap: market cap between $250M and $2B.
- Largest constituent: NovoCure (NVCR), $1.99B market cap.
- Most net new fund positions in Q2 2026: First Tracks Biotherapeutics (TRAX), +147 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.